Dyadic to Attend Industry Events in June

Core Insights - Dyadic International, Inc. is a biotechnology company focused on large-scale protein manufacturing for vaccines and therapeutics, as well as non-pharmaceutical applications like food and wellness [3][4]. Event Participation - Dyadic management will attend several industry events in June 2024, including BIO 2024 in San Diego from June 3-6, Future Food Tech-Alt Proteins in Chicago on June 17-18, and the 2024 NIIMBL National Meeting in Washington, DC from June 25-27 [2]. Technology and Platforms - The company utilizes the fungus Thermothelomyces heterothallica for its gene expression and protein production platforms, specifically the C1-cell protein production platform, which aims to reduce costs and improve performance in biologic vaccines and drugs [4]. - Dyadic has developed the Dapibus™ platform for the rapid and large-scale production of low-cost proteins and other biologic products for non-pharmaceutical uses [4]. Product Pipeline - Dyadic is advancing its proprietary microbial platform technologies, including the DYAI-100 COVID-19 vaccine candidate, along with other biologic vaccines and antibodies [5].